Background: This study explored the prevalence of frontal cells and the relationship between different types of frontal cells classified using the International Frontal Sinus Anatomy Classification (IFAC) and frontal sinusitis. Methods: A retrospective cross-sectional study was conducted with 1006 CT scans of paranasal sinuses. Identification of frontal sinus cells was based on IFAC. The scans were classified into no frontal sinusitis, frontal sinusitis, isolated frontal sinusitis, no sinusitis. Results: Agger nasi cells were the most common (91.9%). The prevalence of supra agger cell (SAC) was 28.7%, while the supra agger frontal cell (SAFC) was only 15.8%, the supra bulla cell (SBC) was 59.7%, the supra bulla frontal cell (SBFC) was 25.8%. Supra orbital ethmoid cell (SOEC) and frontal septal cell (FSC) were identified in 6.9% and 14.3% of the cases, respectively. Patients with SAFCs and SBFCs were significantly more likely to develop frontal sinusitis (Odds Ratio (OR)=1.78, 95% confidence interval (CI) 1.24-2.56 and OR=2.70, 95% CI 1.98-3.66). Isolated frontal sinusitis was found in 10 scans and was associated with the presence of SAC (OR=3.76, 95% CI 1.02-13.90). Conclusion:In Vietnamese adult patients, frontal cells based on IFAC were prevalent and were associated with frontal sinusitis development, including isolated frontal sinusitis.
Objective: To evaluate the efficacy and safety of posterior nasal neurectomy on the treatment of nasal congestion, rhinorrhea, sneezing, and post-nasal discharge in intractable rhinitis patients. Methods Design: Preliminary case series Setting: Tertiary University Medical Center Participants: Ten (10) patients with intractable rhinitis underwent endoscopic posterior nasal neurectomy in both sides. Symptoms were compared pre- and post-operatively one month and one year after surgery using Visual Analog Scale (VAS) scores. Endoscopic pre- and one-month post-operative Lund-Mackay scores were also compared. Results: All four mean nasal symptom scores were reduced significantly at 1-month follow-up for nasal congestion (1.5 ± 1.08 vs 4.1 ± 0.5687, p = .00001), rhinorrhea (0.7 ± 0.823 vs 3.4 ± 0.966, p = .00001) post-nasal discharge (0.9 ± 0.994 vs 2.4 ± 1.5, p = .03), and sneezing (1.1 ± 0.738 vs 3 ± 0.943, p = .02). Mean endoscopic scores were also reduced significantly at one month, from 12.9 ± 2.55 to 4.2 ± 3, p = 0.0001.In the 6 patients that followed up at 1-year, post-operative mean nasal symptoms were still significantly better for congestion (0.6667 ± 0.8165 vs 4 ± 0.632, p = 0.00001), rhinorrhea (0.6667 ± 0.5164 vs 3.67 ± 1.033, p = .001), post-nasal discharge (0.1667 ± 0.40825 vs 2.17 ± 1.835, p = .033), sneezing (0.5 ± 0.54772 vs 3.17 ± 0.983, p = 0.0001). Mean post-operative VAS nasal scores and endoscopic scores were well associated (Correlation Coefficient -.648, p = .048). Conclusion: Posterior nasal neurectomy could be considered as a safety and effective way to treat intractable rhinitis patients in Vietnam. Keywords: Posterior nasal neurectomy, vasomotor rhinitis, allergic rhinitis, vidian neurectomy
Background: The effectiveness of nonabsorbable and biodegradable nasal packing is still controversial, and the choice of nasal packing type can alter the outcome of endoscopic sinus surgery. This study compared the effectiveness of Posisep and Merocel as nasal packing materials with regard to hemostasis, adhesion, wound healing, patient’s satisfaction and health-related quality of life after endoscopic sinus surgery (ESS). Methods: A prospective, randomized, double-blinded, controlled trial was conducted in patients with chronic rhinosinusitis refractory undergoing symmetrical bilateral ESS. At the completion of surgery, a nasal packing (either Merocel or Posisep) was randomly chosen and placed into the middle meatus of each nasal cavity. All patients were scheduled for follow-up visits at 24 hours, 5 days, 3 weeks, and 5 weeks days after surgery. Health-related quality of life was measured using the Sino-Nasal Outcome Test (SNOT-22). The overall inflammatory burden of chronic rhinosinusitis was measured by the Lund-Mackay postoperative endoscopic score (LMES). Results: Among 62 patients included in data analysis (n = 31 for each group), the mean age was 42.4 years and 54.8% were females. Patients with Posisep after ESS had more improvement and better symptoms measured through SNOT-22 and LMES at 24 hours, 5 days, and 3 weeks than those with Merocel after ESS. While some aspects measured by LMES such as discharge and scarring were still better until 5 weeks after surgery, all symptoms measured by SNOT-22 were similar between the 2 groups 5 weeks after surgery. Conclusion: Posisep containing chitosan provided patients with a better quality of life throughout the early recovery period compared with Merocel. Although more studies are needed, our findings support the use of Posisep after ESS.
The authors performed a molecular dynamics simulation to survey the structural and dynamictransition in liquid silica. In detail, research results on the radial distribution function, the coordination number, the characteristics of the domain and average energy per atom showed that silica undergoes three different structural regions when the temperature increases from 2000 to 6000 K. The structural transition occurred most strongly at the temperature range of 4500-5000 K. Furthermore, the authorsinvestigated the cluster function of sets of mobile, immobile and random atoms. The resultsconfirmed that the higher the temperature, the more homogeneous the structure of liquid silica and the structural heterogeneity occurs at a temperature below 3500 K. Finally, the resultsindicated that O atoms are more mobile than Si atoms.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.